test

Delmer Dee Raibourn III

@Avidity Partners Management Lp

Latest period2024 - Q3ReportedManaged Assets$1.96BTotal holdings81
Assets growth rate-16.7%Assets growth rate (2-Q avg)-20.41%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avidity Partners Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.96B in assets, with a quarterly growth rate of -16.7% and a 2-quarter average growth rate of -20.41%. The portfolio is managed by Delmer Dee Raibourn III, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BSXBoston Scientific Corp
Recent Activity
Decreased -17.78%
4.12%
$80.616M
962,000 shares@ $83.8 avg price
ISRGIntuitive Surgical Inc
Recent Activity
Decreased -39.51%
3.72%
$72.806M
148,200 shares@ $491.27 avg price
NTRANatera Inc
Recent Activity
Decreased -27.41%
3.61%
$70.635M
556,400 shares@ $126.95 avg price
ACHCAcadia Healthcare Company In
Recent Activity
Decreased -12.05%
3.19%
$62.459M
985,000 shares@ $63.41 avg price
NBIXNeurocrine Biosciences Inc
Recent Activity
Decreased -6.31%
2.71%
$53.001M
460,000 shares@ $115.22 avg price
JAZZJazz Pharmaceuticals Plc
Recent Activity
Decreased -20.84%
2.45%
$48.018M
431,000 shares@ $111.41 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Decreased -26.38%
2.42%
$47.259M
2.455M shares@ $19.25 avg price
TMOThermo Fisher Scientific Inc
Recent Activity
Decreased -14.24%
2.17%
$42.434M
68,600 shares@ $618.57 avg price
THCTenet Healthcare Corp
Recent Activity
Decreased -31.98%
2.15%
$42.049M
253,000 shares@ $166.2 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
Decreased -21.66%
2.14%
$41.774M
752,000 shares@ $55.55 avg price